A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)

Part of paid clinical trials in Anaheim, California.

Sponsor
Eli Lilly and Company
Study ID
NCT04143802
Phase
PHASE1
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
20 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • LY3437943 — DRUG
    Administered SC
  • Dulaglutide — DRUG
    Administered SC
  • Placebo — DRUG
    Administered SC

Study Details

The main purpose of this study is to learn about the side effects of LY3437943 when given to participants with type 2 diabetes. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. Each enrolled participant will receive injections of LY3437943, dulaglutide, or placebo given just under the skin. For each participant, the study will last up to about 5 months and will include 16 visits to the study center.

Key Dates

Start date
Dec 18, 2019
Status verified
Jan 2021
Primary completion
Dec 28, 2020
Completion
Dec 28, 2020

Study Design

Enrollment
72 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: LY3437943
    LY3437943 administered subcutaneously (SC)
  • Active Comparator: Dulaglutide
    Dulaglutide administered SC
  • Placebo Comparator: Placebo
    Placebo administered SC

Primary Outcome Measure

Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration [ Time Frame: Baseline through Day 106 ]

Locations (4)

FacilityCityStateZIPSite coordinators
Anaheim Clinical Trials, LLCAnaheimCalifornia92801-
Miami Research AssociatesMiamiFlorida33143-
PRA InternationalLenexaKansas66219-
Clinical Trials of Texas, Inc.San AntonioTexas78229-

Find similar trials in Anaheim, CA

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Anaheim Clinical Trials, LLC· Anaheim, CAMiami Research Associates· Miami, FLPRA International· Lenexa, KSClinical Trials of Texas, Inc.· San Antonio, TX

Related Studies